Michelle Carnahan, Thirty Madison, on a human-first approach to healthcare

The Pulse by Wharton Digital Health

In this episode, we interview Michelle Carnahan, President of Thirty Madison. We discuss Michelle’s pivot from pharmaceutical executive to leader of a health tech unicorn and what that means for Thirty Madison going forward. Thirty Madison’s mission is to be a human-first healthcare company delivering specialized care and treatment to everyone. They recently completed a $140M Series C raise led by HealthQuest Capital. They join Maveron and Polaris Partners as lead investors in Thirty Madison.